Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1841 News Items found In the Lab When Loss Is a Gain: New Tumor Suppressor Gene Identified in Follicular Lymphoma Monday, July 3, 2017 The reason certain patients with follicular lymphoma do worse than others may come down to a missing gene. In the Lab Bacteria versus Bacteria: Two Studies Uncover Species of Microbes That Protect against Infections in People with Cancer Tuesday, June 20, 2017 Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria. Science Byte It Takes Two: A Pair of Proteins Coordinate to Direct Development of Embryonic Cells Friday, June 16, 2017 MSK researchers shed light on the signals that determine the fate of embryonic cells. In the Clinic The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers Friday, June 9, 2017 A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality. Finding Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal Thursday, June 8, 2017 The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma. In the News #ASCO17: Post-Conference Roundup of Themes and Trends Wednesday, June 7, 2017 Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics. In the Clinic Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer Monday, June 5, 2017 A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy. In the Clinic Online Symptom-Monitoring Tool Improves Survival for Those Undergoing Chemotherapy for Metastatic Cancer Sunday, June 4, 2017 A study presented at the 2017 annual meeting of the American Society of Clinical Oncology showed that an online tool to monitor patients’ symptoms improved overall survival. In the Clinic Phase III Trial of Targeted Drug Shows Promise in Treating Metastatic Breast Cancer Sunday, June 4, 2017 Investigators found that olaparib extended progression-free survival by an average of three months in women with advanced breast cancer. Finding Could a Blood Test Detect Early-Stage Cancers? Saturday, June 3, 2017 A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment